Molecular Signatures of KRAS-Mutated Lung Adenocarcinoma: Analysis of Concomitant EGFR, ALK, STK11, and PD-L1 Status

BACKGROUND: KRAS mutations are the most common oncogenic driver mutations of non-small cell lung cancer (NSCLC) in the Western world. Mutations of the KRAS gene are most prevalent in the patient population of current and former cigarette smokers. With the recent pivotal approval of a targeted inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jim, Annunziata, Joseph F, Burns, Ethan, Bernicker, Eric H, Olsen, Randall J, Thomas, Jessica S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Focus Section: Precision Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134433/
https://www.ncbi.nlm.nih.gov/pubmed/35634237
http://dx.doi.org/10.1177/2632010X221102054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134433/
https://www.ncbi.nlm.nih.gov/pubmed/35634237
http://dx.doi.org/10.1177/2632010X221102054

Ejemplares similares